Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.
about
A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasmaNevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study.Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs.Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products.Thermal stability and hydration behavior of ritonavir sulfate: A vibrational spectroscopic approach.Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients.Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms.
P2860
Q28533657-5E200B35-8494-4EE9-91EF-7C2C2DA848DDQ33935458-BFE1657F-1420-47EC-9A34-7D2A95B2C8CCQ35826943-A299D568-7DD7-4A59-9BA7-6DB59B05DC2FQ35827661-E9C5E32C-3286-4F28-B0B6-AD56A9EEE982Q37115824-E66B9B8F-1F02-493D-BC95-A85C5217B547Q37245017-25C8B018-4BAD-4151-9869-776C6AAE93A2Q39758059-95736D67-1653-4352-8825-E72E5E1414C1Q42425202-D0389EBD-79F3-47C9-9A8B-F9E39BA976FDQ48504525-5D769671-35CE-4FE3-8D37-1E0B6E074531Q49228013-155E7204-04B5-4D09-975E-2F5E1A4E4851Q54250502-6C2D6A3F-6279-4154-972D-4115F1F05FA1
P2860
Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Determination of twelve antire ...... ormance liquid chromatography.
@en
Determination of twelve antire ...... ormance liquid chromatography.
@nl
type
label
Determination of twelve antire ...... ormance liquid chromatography.
@en
Determination of twelve antire ...... ormance liquid chromatography.
@nl
prefLabel
Determination of twelve antire ...... ormance liquid chromatography.
@en
Determination of twelve antire ...... ormance liquid chromatography.
@nl
P2093
P1476
Determination of twelve antire ...... formance liquid chromatography
@en
P2093
P304
P356
10.1016/S0378-4347(00)00225-5
P577
2000-07-01T00:00:00Z